Camber Capital Management LP's Q1 2023 13F: 7 new positions, 5 exits

Form 13F-HR for the quarter ended Mar 31, 2023 · filed May 15, 2023 · 40 reported positions · accession 0001654954-23-006453

What changed this quarter

Camber Capital Management LP's changes in reported equity positions, Q1 2023
Activity Security Weight before Weight now Change Shares Shares %
New BAXTER INTL INC (BAX) — 4.2% +4.2 pts +3M sh new
Reduced ALIGN TECHNOLOGY INC (ALGN) 2.8% 0.6% −2.2 pts −325K sh −87%
Reduced SANOFI (SNY) 11.9% 10.2% −1.6 pts −1.5M sh −21%
Reduced SAREPTA THERAPEUTICS INC (SRPT) 5.7% 3.5% −2.1 pts −500K sh −40%
Exited SEAGEN INC (SGEN) 2.2% — −2.2 pts −500K sh −100%
Increased WALGREENS BOOTS ALLIANCE INC (WBA) 6.5% 7.7% +1.1 pts +1.5M sh +30%
Exited QIAGEN NV (QGEN) 1.3% — −1.3 pts −750K sh −100%
Reduced TEVA PHARMACEUTICAL INDS LTD (TEVA) 2.2% 0.9% −1.3 pts −4M sh −57%
New CONMED CORP (CNMD) — 1.2% +1.2 pts +325K sh new
Increased GSK PLC (GSK) 4.6% 5.6% +1.0 pts +850K sh +23%
Increased UNIVERSAL HLTH SVCS INC (UHS) 8.4% 8.3% 0.0 pts +225K sh +13%
Exited SAGE THERAPEUTICS INC (SAGE) 0.9% — −0.9 pts −700K sh −100%
New CENTENE CORP DEL (CNC) — 0.9% +0.9 pts +400K sh new
Increased VIATRIS INC (VTRS) 7.8% 7.4% −0.4 pts +2.5M sh +13%
Exited CARDIOVASCULAR SYS INC DEL (CSII) 0.6% — −0.6 pts −1.3M sh −100%
New GLOBUS MED INC (GMED) — 0.6% +0.6 pts +305K sh new
Reduced PELOTON INTERACTIVE INC (PTON) 0.6% 0.3% −0.3 pts −1.25M sh −63%
New HERBALIFE NUTRITION LTD (HLF) — 0.5% +0.5 pts +825K sh new
Reduced PTC THERAPEUTICS INC (PTCT) 3.7% 4.1% +0.5 pts −250K sh −9%
Reduced TENET HEALTHCARE CORP (THC) 6.8% 7.8% +1.0 pts −150K sh −4%
New CUREVAC N V (CVAC) — 0.3% +0.3 pts +1.25M sh new
Increased INOGEN INC (INGN) 0.2% 0.4% +0.2 pts +670K sh +220%
New THE BEAUTY HEALTH COMPANY (SKIN) — 0.2% +0.2 pts +500K sh new
Exited ENANTA PHARMACEUTICALS INC (ENTA) 0.2% — −0.2 pts −110K sh −100%
Increased ZIMVIE INC (ZIMV) 0.8% 0.8% 0.0 pts +650K sh +25%
Increased REPLIMUNE GROUP INC (REPL) 1.0% 0.8% −0.2 pts +250K sh +25%
Increased NUVASIVE INC (NUVA) 0.7% 0.8% +0.1 pts +100K sh +20%
Increased EXELIXIS INC (EXEL) 0.8% 1.0% +0.3 pts +200K sh +15%

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 66.4% of the equity book

Changes in the top 10 this quarter: MYGN entered · BAX entered · SRPT left · PTCT left

# Security Weight before Weight now
1 SANOFI (SNY) 11.9% 10.2%
2 UNIVERSAL HLTH SVCS INC (UHS) 8.4% 8.3%
3 TENET HEALTHCARE CORP (THC) 6.8% 7.8%
4 WALGREENS BOOTS ALLIANCE INC (WBA) 6.5% 7.7%
5 VIATRIS INC (VTRS) 7.8% 7.4%
6 GSK PLC (GSK) 4.6% 5.6%
7 MYRIAD GENETICS INC (MYGN) 3.6% 5.5% Entered the top 10
8 ZIMMER BIOMET HOLDINGS INC (ZBH) 5.6% 5.5%
9 SELECT MED HLDGS CORP (SEM) 4.2% 4.2%
10 BAXTER INTL INC (BAX) 0.0% 4.2% Entered the top 10
— SAREPTA THERAPEUTICS INC (SRPT) 5.7% 3.5% Left the top 10
— PTC THERAPEUTICS INC (PTCT) 3.7% 4.1% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
New INVESCO QQQ TR (QQQ) Put 0 1M $321M
Exited VIATRIS INC (VTRS) Call 5M 0 $0